Fresh analysis indicates that individuals who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who halt traditional diet and exercise regimens.
Findings released in a leading medical journal shows that while overweight people frequently drop substantial amounts of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"Individuals purchasing these medications must be cognizant of the potential of fast rebound weight gain when the therapy ends," warns lead investigator Dr. Susan Jebb.
Such speed of regain implies a reversion to starting weight within about 18 months.
Weighing Treatments
The analysis, which examined 37 of studies involving over 9,000 of participants, contrasted the outcomes of these new drugs with other pills.
Researchers emphasize that individuals who shed pounds through lifestyle changes alone generally see a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.
The Reason for the Fast Rebound
Experts suggest the way of the injections is key to understanding the amplified weight return.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing the hormone concentrations several times higher than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and could reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.
"Stopping of this medication results in appetite is no longer kept in check, making overeating a significant risk."
A Chronic Issue?
Health authorities recommend the jabs for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, given the significant potential of weight regain, the therapy might need to be life-long.
This perspective is reinforced by pharmaceutical companies, who note that the results "highlight the chronic character of obesity," comparing it to managing conditions like diabetes.
Patient Experiences
Individuals who have discontinued the jabs describe a intense return of cravings.
"I experienced a trigger that goes on and you're instantly ravenous," described a patient.
The struggle is compounded if individuals have not adopted lasting dietary or behavioural modifications during treatment.
Significant Adoption
Recent estimates indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.
- Use is more common among females than men.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion access the drugs through private prescriptions rather than the NHS.
Finally, experts stress that while the jabs are potent tools for weight loss, they are not a magic cure and long-term success likely depends on integrated behavioural changes.
